Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype - Wikidata - wikimedia - TriplyDB

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

http://www.wikidata.org/entity/Q24613907

about

Atypical hemolytic uremic syndrome Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea Critical appraisal of eculizumab for atypical hemolytic uremic syndrome Advances and challenges in the management of complement-mediated thrombotic microangiopathies Hemolytic uremic syndrome Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature Management of hemolytic-uremic syndrome in children Current treatment of atypical hemolytic uremic syndrome Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry Complement regulator CD46: genetic variants and disease associations Complement System Part II: Role in Immunity A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Haemolytic uraemic syndrome.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutations.Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome.Age-related penetrance of hereditary atypical hemolytic uremic syndrome.Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.Thrombotic microangiopathy and associated renal disorders.Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.Multifaceted hemolytic uremic syndrome in pediatrics.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Complement disorders and hemolytic uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

P2860

Q21202864-4C645142-EDC8-4FB8-AEAA-AEF275218F35 Q24605432-7CE26E9A-8DB6-49BC-8F17-2392BAAC8669 Q24622189-F85A9E8C-75FF-46A5-A886-FB5FAE9A72F9 Q26739894-3572920D-F846-41AD-8D5A-78308A740C02 Q26750692-7A2FBF2E-245C-448D-8984-4B325A61E8A5 Q26796453-596AE4BA-7658-4F71-B8EA-DA263BE86C14 Q26799054-F6C38D59-87A7-4B11-960E-081EF89E05D3 Q26864297-6FF3B330-DC42-4C41-8AA1-2AD71045380B Q27002576-5570A45C-0FCB-42F6-9ED6-A419C85F0606 Q27003211-82938BAD-350C-45B4-875A-5FF88BA3B413 Q28067041-AD40FDDF-55A5-4624-8563-99C5891D320E Q28068275-7C1EB12B-920F-4A1B-A05A-B937E5FDAB91 Q28263110-912E5D1D-1D51-4F1B-82B7-EA197BE60D85 Q28263460-442C4959-1DB9-4E71-AD52-9FAA090E20EC Q28661698-55A9A186-B499-4ADA-8D08-62686D0976FB Q30244707-848E163A-5A3F-442C-9D95-FAAA974C6165 Q30276550-F0EE835A-C4EE-4706-9184-24ED489DFA74 Q31010561-4C9A224C-7079-4358-BD09-AA1B75B5A508 Q33393107-ADF70E40-60F7-47DE-89B2-B830CB606E67 Q33394010-D682D621-B9CD-426C-BA6E-DBBCBC612C1E Q33395944-ADBF64F2-7611-436B-AFB9-45C3AF78D6C0 Q33396013-F328D043-859B-4506-91B7-4780EDD80516 Q33396528-788C43BC-C4AC-4F2A-A4D1-9E823670FF7C Q33397115-3C7A5293-0169-4C35-94E0-D79567BFBC4E Q33398635-5291C08B-1D46-4C00-98B3-AFE8D53EC945 Q33399198-C69097E2-1CE0-44AA-82BE-16043240B08F Q33400211-E6BFC0D2-DAFE-4A6B-BABD-CFAB867164A2 Q33401621-77ECFF50-3FCA-46D6-81C3-E8392C1846B2 Q33402372-A129F447-A95F-432A-AD9C-31C810017988 Q33402795-219443B5-4F7B-4B78-8EC1-B10FBD208855 Q33403359-2F6DE833-D49B-4852-B6A0-6DF6A264E636 Q33403607-B0670D2B-B13B-4D71-A8E3-F1ABCC94147E Q33404640-AFFAE13B-348D-4F07-84D2-33C8B756F3EB Q33404847-376B4E5D-1F2F-46F7-8078-97DE1177CF1F Q33404888-35D3DEB2-72E8-4B99-806D-0827F3BEBE25 Q33405246-41C6051B-937A-441C-81B3-2E85F16B642D Q33405452-7B748176-693C-4E09-BAE4-7BAFF2BFB268 Q33405522-2C79F7D9-472A-44CE-BAF2-F024E2E9F1C8 Q33405802-3D695E99-B71B-417C-B567-37E44BCB054F Q33406025-B4814035-5636-4FE3-8108-4100EE5DB1ED

P2860

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

http://www.wikidata.org/entity/Q24613907

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Relative role of genetic compl ...... r impact on clinical phenotype

@ast

Relative role of genetic compl ...... r impact on clinical phenotype

@en

Relative role of genetic compl ...... r impact on clinical phenotype

@nl

type

label

Relative role of genetic compl ...... r impact on clinical phenotype

@ast

Relative role of genetic compl ...... r impact on clinical phenotype

@en

Relative role of genetic compl ...... r impact on clinical phenotype

@nl

prefLabel

Relative role of genetic compl ...... r impact on clinical phenotype

@ast

Relative role of genetic compl ...... r impact on clinical phenotype

@en

Relative role of genetic compl ...... r impact on clinical phenotype

@nl

P1433

Q24613907-5CED3844-8ABC-44CB-AE2B-C74E6FB1C335

P1476

Q24613907-0B8CE981-40DA-4EB8-9FF8-FD08259377AF

P2093

Q24613907-08A0E999-68F3-44E8-B1C9-13FE58FF914A

Q24613907-142078A8-2644-460A-936D-33DD625B464D

Q24613907-27709D2D-F18C-45D0-9551-743EAB3EDBCF

Q24613907-449B19BF-16BB-4E80-B6DD-28A3C8BDD23F

Q24613907-708D0B6B-41C6-43C0-B6FC-6FD01CEAD693

Q24613907-70E27C44-8DB1-442F-A939-4F522C8130BC

Q24613907-715B7457-6DBF-4D25-A3C2-5E588ECB9BEC

Q24613907-76D437FD-6F85-4081-898F-E3A171E3E267

Q24613907-8581F991-F2CB-41B1-B119-5E8C4AD21C96

Q24613907-90DA0DF6-C7ED-4C52-9239-FE00D26EFBD9

P2860

Q24613907-0AF2CA32-CD1E-45F6-A411-0CA1462F89BD

Q24613907-0D5000B9-58F2-4157-B327-89053D2FAB0D

Q24613907-10618AD7-246B-429C-8E5A-6E1147500D55

Q24613907-1F84A70C-A084-4194-972A-312043102631

Q24613907-242A6A7A-07BC-40CD-82AD-6E9600680D49

Q24613907-259BA950-B55E-4030-9144-34838DA55A09

Q24613907-2A0751AF-D031-4EEF-B5C2-8F266882B543

Q24613907-2CC77BA6-2520-4F38-9CBF-0A9231F70661

Q24613907-31127764-41F6-477F-92E7-32B7FB41AE3B

Q24613907-4E2CCB77-B8A3-4B32-8B1D-2BBE977DEEB8

P304

Q24613907-4337F69B-86C8-454D-A744-5144A1A69671

P31

Q24613907-1849EFD1-CD95-4E34-8D28-9833407C5739

P3181

Q24613907-7AAB07DC-545D-4836-9FEC-29ED9C70F5CE

P356

Q24613907-1270BD01-88A1-4133-9491-F2D103259ABF

P407

Q24613907-9BDA2DC6-7B37-4555-8177-6375C5E55DD3

P433

Q24613907-3520C6F6-0A90-47D0-B4E2-3B0FC1DA3DEA

P478

Q24613907-573BBC7D-93D9-4D11-896C-A761F584DADA

P50

Q24613907-088ED6E0-928C-4244-A9F6-F0BF4B670466

Q24613907-AA5A7482-52CD-4166-BB6D-6E7E77649ADE

Q24613907-BE589A1B-0C2E-442B-9576-A9E41DC00619

P577

Q24613907-7227DAE9-0D6B-4975-B2E2-E647D97BC381

P5875

Q24613907-336467C8-98E7-4086-B07A-DA00F9FCB98D

P698

Q24613907-9F6EDAF2-C8D0-4034-B624-86633F478BEB

P932

Q24613907-9F6560F7-F2FF-49E3-9B18-748111509808

P3181

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Relative role of genetic compl ...... r impact on clinical phenotype

@en

P2093

Annalisa Sorosina

http://www.w3.org/2001/XMLSchema#string

Chiara Fenili

http://www.w3.org/2001/XMLSchema#string

Chiara Mossali

http://www.w3.org/2001/XMLSchema#string

Elena Bresin

http://www.w3.org/2001/XMLSchema#string

Erica Daina

http://www.w3.org/2001/XMLSchema#string

Federica Castelletti

http://www.w3.org/2001/XMLSchema#string

Gaia Pianetti

http://www.w3.org/2001/XMLSchema#string

Irene van der Meer

http://www.w3.org/2001/XMLSchema#string

Jessica Caprioli

http://www.w3.org/2001/XMLSchema#string

Marina Noris

http://www.w3.org/2001/XMLSchema#string

P2860

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene

Soluble thrombomodulin protects ischemic kidneys

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease.

Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

P304

1844-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2355596

http://www.w3.org/2001/XMLSchema#string

P356

10.2215/CJN.02210310

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

Edward M. Conway

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44902185

http://www.w3.org/2001/XMLSchema#string

P698

20595690

http://www.w3.org/2001/XMLSchema#string

P932

2974386

http://www.w3.org/2001/XMLSchema#string